uniQure (QURE) Non-Current Assets (2015 - 2026)
uniQure (QURE) posted quarterly Non-Current Assets of $150.8 million for Q2 2026, down 14.45% year-over-year from $176.3 million in Q2 2025, and down 7.44% quarter-over-quarter from $163.0 million in Q1 2026.
uniQure (QURE) Non-Current Assets (2015 - 2026) Analysis & Trends
uniQure's Non-Current Assets history runs 12 years deep, the most recent figure standing at $150.8 million for Q2 2026.
- In Q2 2026, Non-Current Assets fell 14.45% year-over-year to $150.8 million; the TTM figure through Jun 2026 stood at $150.8 million (down 14.45% YoY), while the FY2025 annual figure was $168.9 million, up 1.61% from the prior year.
- Non-Current Assets for Q2 2026 stood at $150.8 million, down from $163.0 million in the prior quarter.
- The five-year high for Non-Current Assets was $228.2 million in Q4 2022, with the low at $138.9 million in Q2 2024.
- The 5-year median for Non-Current Assets is $175.2 million (2024), against an average of $175.1 million.
- The sharpest annual moves came in 2022 and 2024: Non-Current Assets jumped 119.49% in 2022, then decreased 25.26% in 2024.
- uniQure's Non-Current Assets stood at $228.2 million in 2022, then declined by 21.19% to $179.8 million in 2023, then decreased by 7.56% to $166.2 million in 2024, then advanced by 1.61% to $168.9 million in 2025, then dropped by 10.71% to $150.8 million in 2026.
- Business Quant data shows QURE's Non-Current Assets at $150.8 million in Q2 2026, $163.0 million in Q1 2026, and $168.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.96 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 294.93 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.96 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 18.06 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 938.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 468.65 Mn |
| 10 | uniQure | 3.37 Bn | 3.37 Bn | 5.49 Mn | 150.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 150.83 Mn |
| Mar 31, 2026 | 162.96 Mn |
| Dec 31, 2025 | 168.92 Mn |
| Sep 30, 2025 | 172.19 Mn |
| Jun 30, 2025 | 176.32 Mn |
| Mar 31, 2025 | 169.98 Mn |
| Dec 31, 2024 | 166.25 Mn |
| Sep 30, 2024 | 181.67 Mn |
| Jun 30, 2024 | 138.88 Mn |
| Mar 31, 2024 | 174.05 Mn |
| Dec 31, 2023 | 179.84 Mn |
| Sep 30, 2023 | 177.92 Mn |
| Jun 30, 2023 | 185.81 Mn |
| Mar 31, 2023 | 188.36 Mn |
| Dec 31, 2022 | 228.19 Mn |
| Sep 30, 2022 | 173.66 Mn |
| Jun 30, 2022 | 177.91 Mn |
| Mar 31, 2022 | 178.94 Mn |
| Dec 31, 2021 | 180.94 Mn |
| Sep 30, 2021 | 180.86 Mn |